Related references
Note: Only part of the references are listed.Proteomics analysis of host cells infected with infectious bursal disease virus
Xiaojuan Zheng et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Escape and compensation from early HLA-B57-Mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A
Mark A. Brockman et al.
JOURNAL OF VIROLOGY (2007)
Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal
Huirong Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A
Jesse M. Damsker et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Fusion of cyclophilin a to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses
Torsten Schaller et al.
JOURNAL OF VIROLOGY (2007)
Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia
Changlian Zhu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis
Judith M. de Bont et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death
Kyu Jin Choi et al.
CANCER RESEARCH (2007)
Mutation in the loop C-terminal to the cyclophilin A binding site of HIV-1 capsid protein disrupts proper virus assembly and infectivity
Samir Abdurahman et al.
RETROVIROLOGY (2007)
Overexpression of hedgehog signaling molecules and its involvement in the proliferation of endometrial carcinoma cells
Yu-Zhen Feng et al.
CLINICAL CANCER RESEARCH (2007)
Proteomic analysis of the resistance to Aplidin in human cancer cells
Laura Gonzalez-Santiago et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Mass spectrometric proteomics profiles of in vivo tumor secretomes:: Capillary ultrafiltration sampling of regressive tumor masses
Chun-Ming Huang et al.
PROTEOMICS (2006)
Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR
Mu-Chin Shih et al.
MOLECULAR CARCINOGENESIS (2006)
Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells
N. Konstantakopoulos et al.
MOLECULAR CARCINOGENESIS (2006)
Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147
M Li et al.
CANCER (2006)
Tumorigenesis of K-ras mutation in human endometrial carcinoma via upregulation of estrogen receptor
Zheng Tu et al.
GYNECOLOGIC ONCOLOGY (2006)
Proteomic analysis of bovine brain G protein γ subunit processing heterogeneity
LA Cook et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells
J Suzuki et al.
CIRCULATION RESEARCH (2006)
Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status
KI Pappa et al.
GYNECOLOGIC ONCOLOGY (2006)
The association between p53 expression, stage and histological features in endometrial cancer
N Ragni et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2005)
Variable MLH1 promoter methylation patterns in endometrial carcinomas of endometrioid subtype lacking DNA mismatch repair
KE Helmle et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies
I Ciechomska et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Stable RNA interference-mediated suppression of Cyclophilin A diminishes non-small-cell lung tumor growth in vivo
BA Howard et al.
CANCER RESEARCH (2005)
Altered protein expression in endometrial carcinogenesis
T Yoshizaki et al.
CANCER LETTERS (2005)
The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP
M Münz et al.
CANCER LETTERS (2005)
Cyclosporin A inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells
LA Eckstein et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and clCAT with multidimensional liquid chromatography and tandem mass spectrometry
L DeSouza et al.
JOURNAL OF PROTEOME RESEARCH (2005)
BRAF mutation in endometrial carcinoma and hyperplasia: Correlation with KRAS and p53 mutations and mismatch repair protein expression
YZ Feng et al.
CLINICAL CANCER RESEARCH (2005)
Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction
SH Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis
C Candé et al.
ONCOGENE (2004)
Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry
JJ Shen et al.
CANCER RESEARCH (2004)
Proteomics of buccal squamous cell carcinoma: The involvement of multiple pathways in tumorigenesis
J Chen et al.
PROTEOMICS (2004)
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer
BA Howard et al.
LUNG CANCER (2004)
Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A
SK Liu et al.
NUCLEIC ACIDS RESEARCH (2004)
Cyclophilin A is a proinflammatory cytokine that activates endothelial cells
ZG Jin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
L1 (CD171) as a novel biomarker for ovarian and endometrial carcinomas
M Fogel et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2004)
Protein expression profiling of endometrial malignancies reveals a new tumor marker: Chaperonin 10
ECC Yang et al.
JOURNAL OF PROTEOME RESEARCH (2004)
Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin
L Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes
Q Huai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Clinical proteomics: Translating benchside promise into bedside reality
EF Petricoin et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer
S Memarzedeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21
LA Meza-Zepeda et al.
ONCOGENE (2002)
Proteome analysis of hepatocellular carcinoma
SO Lim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Cyclophilin A is a secreted growth factor induced by oxidative stress
ZG Jin et al.
CIRCULATION RESEARCH (2000)
Isolation, characterization and targeted disruption of mouse Ppia:: Cyclophilin A is not essential for mammalian cell viability
J Colgan et al.
GENOMICS (2000)
Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
HA Coller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)